InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Discover the full record of transactions filed by Jean-Michel CARLE GRANDMOUGIN, Chief Executive Officer. Director active across 1 companies, notably EUROBIO-SCIENTIFIC. In total, 5 filings have been logged. Total volume traded: €573k. The latest transaction was filed on 18 May 2022 (Apport). Regulator: AMF. All data is free.
Declarations5 total
€22m876,909 shares@ €25.288.75% mcap97.5% of flow
ActionHors plateforme de négociation
2022DD843698·
055,380 shares0
ActionHors plateforme de négociation
2022DD832636·
€125,4124,385 shares@ €28.60020.049% mcap0.6% of flow
ActionEuronext Growth Paris
2022DD814041·
€28,0481,402 shares@ €20.00540.011% mcap0.1% of flow
ActionEuronext Growth Paris
2021DD759103·
€419,52220,500 shares@ €20.46450.17% mcap1.8% of flow
ActionEuronext Growth Paris
2021DD744964·
5 of 5 declarations
About Jean-Michel CARLE GRANDMOUGIN
Jean-Michel Carle Grandmougin is the Chairman & CEO of Eurobio-Scientific. He leads the company with a vision focused on innovation and the development of biotechnology solutions.
